PPMD announced today that they will award Dr. M. Carrie Miceli and her team at UCLA’s David Geffen School of Medicine and College of Letters and Science, a $50,000 exploratory grant to continue their evaluation of exon skipping boosters for the treatment of Duchenne.
2014 was a historic year in our community. 2015 promises to be another critical year in Duchenne and we need you to help keep the momentum going! Just look at the ‘to-do’ list:
Added by Ryan Fischer on January 28, 2015 at 1:30pm — No Comments
Vaccinations are very, very important to protect us against infection and disease – but they are also very, very confusing.
Some vaccines are “live,” some are “attenuated (killed),” some protect against viral…Continue
Added by Kathi Kinnett on January 23, 2015 at 12:00pm — No Comments
For the last two years, global biopharmaceutical company Bristol-Myers Squibb (BMS) has organized a day when all of their drug development project teams from across the world would have the opportunity to take some time to listen…Continue
“We were the generation that was hoped for… And now we’re here.” L. Vance Taylor
The PPMD Adult Advisory Council (PAAC) serves to ensure that the voices of adults living with Duchenne and Becker…Continue
Added by Annie Kennedy on January 15, 2015 at 1:00pm — No Comments
I sit here in my home office on a snowy January day in Maryland, and I think about where I am at now in life and how I got here. As a naïve, newly minted Ph.D. in 1980, it wasn’t inevitable, or even predictable, that I would ultimately join all of you in the fight to end Duchenne. But, I’m really glad…Continue
As you may have noticed, despite receiving the 2014-2015 influenza (flu) vaccine, many people have gotten the flu. It turns out that the vaccine contained inactivated (dead) virus that protected against 3 strains of influenza: